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   ABSTRACT   
Importance: Older men are at risk of dying from melanoma. 
Objective: To assess uptake of clinical skin examination (CSE) and clinical outcomes of CSEs.  
Design: Behavioral randomized-controlled trial. 
Setting: Video-based intervention in men 50 years or older. 
Participants: Between June and August 2008, men 50 years or older were randomized to receive 
either a video-based intervention (n=469), or brochures only (n=461, response rate=37%), and 
were interviewed seven months later (n=870, 94% retention).  
Intervention: video on skin self-examination and skin awareness and written information 
materials; Control: written information materials only.  
Main Outcome Measures:  1) Participants who reported a CSE were asked for type of CSE 
(skin spot, part body or whole body), who initiated it, whether the doctor noted any suspicious 
lesions, and if yes, how it was managed; 2) doctors completed a case report form that included:  
type of CSE; who initiated it; number of suspicious lesions detected; how the lesion(s) was 
managed (excision, monitoring, referral); and 3) pathology reports for excised/biopsied lesion(s). 
Results:  Overall, 540/870 men who self-reported a CSE since receiving intervention materials, 
321/540 (59%) consented for their doctor to provide medical information (received for 
n=266/321, 83%).   Uptake of any CSE was similar between groups (246/436, 56% intervention; 
229/434, 53% control group participants), but the intervention group were more likely to self-
report a whole-body CSE (145/436, 35% intervention vs. 112/434, 27% control, p=0.01). Two 
melanomas, 29 squamous cell carcinomas, and 38 basal cell carcinomas were diagnosed, with  
higher proportion of malignancies in the intervention (60%) compared to control (40%; p=0.03). 
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Attitudes, behaviors, and skin cancer history were associated with higher odds of CSE and skin 
cancer diagnosis.  
Conclusions and Relevance: A video-based intervention may increase whole-body CSE and 
skin cancer diagnosis in older men.  
Trial Registration: Australian New Zealand Clinical Trials Registry N12608000384358 
Key words: clinical skin examination, malignant melanoma, skin cancer, video intervention, 
males, prevention 
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  INTRODUCTION  
Melanoma is a common malignancy of the skin. In Australia in 2008, the age-standardised rate 
was 65/100,000,1,2 compared to 21/100,000 3,4 in the USA. While a stabilisation of incidence 
rates in younger birth cohorts has been observed,5,6 incidence in older age groups is continuing to 
increase in the USA, Australia and Europe. 7,8 In the USA, death rates from melanoma have 
decreased in women whereas they have increased in men.9  
Removing melanomas when they are thin (< 1mm) is associated with lower morbidity and 
mortality.10-12 Early detection is an important strategy to reduce the burden of melanoma,13 and 
can be achieved through visual inspection by a lay person (skin self examination (SSE)) or by a 
clinician (clinical skin examination (CSE)). In 1996, a population-based case-control study 
suggested that SSE was associated with a survival benefit.14 A case-control study in Queensland 
(QLD) showed that melanomas detected during deliberate examinations (by a lay person or a 
doctor) were thinner. 15 Having one whole-body CSE within the past three years can reduce the 
risk of being diagnosed with a thick melanoma by 14%. 16 This may improve ten-year survival 
rates among screened (92.6%) versus unscreened (90.4%) melanoma survivors 16 although lead 
time bias needs to be considered. CSEs have also been shown in other studies to detect thin 
melanoma and reduce incidence of thick melanomas.15, 17, 18,19,20 A skin cancer screening project 
in Germany reported a reduction in mortality from melanoma in one state offering screening by 
CSE, compared to states not offering .21 
Approximately 30% of people attend a doctor for a CSE at least every three years, 22 but older 
men are less likely than other populations to do so. 16,21 In addition, others have found that men 
compared to females have worse survival even after controlling for tumour thickness, suggesting 
that sex-specific biological factors may play a role in survival. Older men are also more likely to 
be diagnosed with thick melanomas and their melanoma is more likely to be fatal.23 A cost-
analysis estimated that providing CSEs to men 50+ years would incur similar healthcare costs to 
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other early detection programs such as mammography for breast cancer, or faecal occult blood 
testing for colorectal cancer.24 Despite this, melanoma screening is currently not recommended 
in most countries 25 due to lack of randomized trial evidence for mortality benefit (although one 
trial is of one currently ongoing).21,22 
The present study forms part of a randomized controlled trial of a video-based intervention 
aiming to improve SSE, skin awareness and CSE behaviors in men 50+ years. Previous reports 
from this trial have focussed on methodology and SSE outcomes.26,27 This analysis focussed on 
the pre-specified secondary aim of the trial to assess CSE uptake and outcomes. It aims to assess 
whether the intervention increased the proportion of men who presented to a doctor for a CSE, 
who received a whole-body CSE, and who were diagnosed with skin cancer. A further aim was 
to determine factors other than the intervention or control condition associated with having a 
CSE or skin cancer diagnosis during the trial.  
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METHODS 
Ethics approval was received from The Queensland University of Technology’s ethics committee 
(approval number QUT 0600000645). Between June and August 2008, 930 men aged 50+ years 
were recruited through random selection from the QLD electoral roll (response rate 37%) (Figure 
1). Eligibility criteria included proficiency in English, access to a DVD player and no previous 
history of melanoma. Participants were enrolled into a randomized controlled trial, the Skin 
Awareness Study (Australian New Zealand Clinical Trials Registry N12608000384358).  
 
Intervention and control conditions: Intervention participants received video-based plus written 
skin awareness educational materials, and control group participants received the same written 
educational material only. 27 The intervention was underpinned by the health belief model 
(HBM). 28 The video highlighted the seriousness of a melanoma diagnosis (perceived seriousness 
according the HMB) risk factors for melanoma and the increased risk of men older than  50 
(perceived susceptibility), modelled a whole-body SSE (self-efficacy), presented a melanoma 
surgeon who encouraged SSE (cues to action) and presentation to a doctor for a whole-body 
CSE, and showed a CSE being performed (overcome barriers).  A national sports personality 
along with melanoma survivors encouraged men to become skin aware (benefit).  
Main outcome measures: Outcomes were the prevalence and frequency of having had any type 
or whole-body  CSEs since baseline, as well as clinical and histopathological outcomes of skin 
lesions treated during the past 6 months. Overall, 469 men were randomized to the intervention 
group, and 461 to the control group. Baseline telephone survey results were available for 929 
participants. 27,26 At baseline, 81% of men reported that a doctor had ever checked any part of 
their skin for early signs of skin cancer, and 39% had had a whole body CSE within the past 12 
months.26 
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For the present analysis, we used data from a telephone interview administered seven months 
after baseline, along with information from participants’ doctors. Participants were asked if they 
had undergone CSE within the past six months. The validity of CSE self-report was previously 
established (concordance between self-report and doctor report 94% for CSE within the past 3 
years), with some evidence for telescoping when the time interval assessed was shorter 
(concordance 74% for CSE within past 12 months).29 If participants reported having had a CSE, 
we asked about the type of CSE (skin spot, part body or whole body), who initiated it (the 
participants themselves or their doctor during a consultation for another reason), whether the 
doctor noted any suspicious lesions, and if yes, how it was managed. With participant consent 
we asked the doctor to complete a case report form that included:  type of CSE; who initiated it; 
number of suspicious lesions detected; how the lesion(s) was managed (non-surgical treatment, 
surgical treatment (excision/biopsy), monitoring, referral); and we obtained pathology reports for 
excised/biopsied lesion(s).  Analysis was restricted to CSEs completed after the study starting 
date, 1st October 2008, and before the seven months interview. 
Statistical analysis 
Analyses were performed using SAS 9.2 and SAS 9.3 software.  Descriptive analyses were 
conducted, and Chi-square tests and Wilcoxon tests were used to assess differences in self-
reported outcomes between intervention and control groups. Chi-square tests were also used to 
compare the distribution of doctors’ responses to each question in the case-report forms and 
diagnostic outcomes between treatment arms. Agreement between patient reported and doctor 
reported data was assessed using Cohen’s kappa. 
Bivariate logistic regression analyses of demographic and clinical factors, phenotypic 
characteristics, SSE behaviors, attitudes and social supports associated with having at least one 
part or whole-body self-reported CSE during the study period were initially conducted. 
Multivariable logistic regression was then used to assess which of these characteristics were 
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independently associated with self-reported CSE after adjustment for other variables (key 
demographic, skin cancer risk factors, sun protection behaviours, and attitudes and beliefs 
a described previously26), including randomization to intervention or control groups. Factors 
with a p-value of <0.2 were initially included in the multivariable logistic regression, removed 
one by one then re-entered while observing changes in the likelihood ratio to derive the most 
parsimonious model. Terms were retained if p-value<0.05 within the multivariable model. 
Similarly baseline factors independently associated with being diagnosed with a skin malignancy 
(melanoma, squamous cell carcinoma (SCC) or basal cell carcinoma (BCC)) were established. 
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  RESULTS 
 Once baseline interviews were complete (Table 1 presents baseline characteristics), participants 
were randomized by computer-generated random number list generated separately from other 
study procedures by the study statistician (PB) into the intervention or control groups stratified 
by area of residence (south east corner of QLD versus rest of QLD). Due to the nature of the 
intervention it was not possible to mask participants for their group assignment; however 
telephone interviewers were working for a professional telephone survey company independent 
from the research team and blinded to participants’ allocation. Seven months follow-up 
telephone interviews were completed by 870/930 men (94% of those enrolled); Figure 1 
summarises participant flow. Demographic characteristics at baseline have been described 
previously. 26  
Self-reported outcomes: Overall at the 7-month interview, 475/870 men (55%) self-reported that 
a doctor had deliberately checked any part of their skin during the past 6 months, and this did not 
differ between intervention (246/436, 56%) and control group (229/434, 53%; p =0.28). There 
was also no difference in the number of participants who reported that the doctor looked at a skin 
spot during a consultation for another reason (intervention 114/436, control 112/434). However, 
participants in the intervention group (154/436, 35%) were significantly more likely compared to 
controls (118/434, 27%; p=0.01) to report a whole-body CSE during the past six months.  
Among participants who reported either a dedicated CSE or skin spot check during another 
consultation, Table 1 compares the distribution of participants’ self-reported outcomes of these 
consultations. Men in the intervention group were more likely to have been asked by their doctor 
to return for a follow-up exam (p<0.01), but there was no difference between intervention or 
control groups in relation to self-reported skin lesion treatment (Table 2).  
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In the multivariable model, baseline factors positively associated with a self-reported CSE within 
the first six months of the trial included: have a regular GP (OR= 1.49; 95% CI 1.15-1.92);  
having had a spot or mole removed in the past (OR=1.45; 95% CI 1.24-1.71); currently 
concerned about a spot or mole (OR=1.31; 95% CI 1.10-1.56); checked own skin in the past 6 
months (OR=1.15; 95% CI 1.00-1.33); a history of CSE in the previous 12 months (OR=1.47; 
95% CI 1.26-1.70), and sometimes/usually wearing  a hat (OR=1.34; 95% CI 1.01-1.78). Within 
men in the intervention group who reported at least any CSE, those who watched the DVD more 
than once were more likely to report a whole-body CSE (62%) than those that watched the DVD 
once (55%) or did not watch it (50%), however, this difference was not statistically significant 
(p=0.34). 
Of men who reported a CSE in the previous six months, 321/540 (59%, 159 intervention, 162 
control) gave consent for their doctor to be contacted by the study team for further details about 
the CSE. Men who had black hair colour, no previous history of skin excision or treatment, and 
no CSE within the 12 months prior to baseline were less likely to consent for their doctor to be 
contacted (all p<0.05). Men who did not provide consent to contact their doctor were less likely 
to self-report that at least one or more skin lesions were found during the CSE (84/216; 39%) 
compared to men who gave permission (165/321; 51%) p=0.004; and the distribution of their 
self-reported number of lesions requiring treatment was also lower (median =2; range =1-15) 
than in men who consented to doctor contact (median = 2; range =1-28); p <0.001. 
In total, medical case report forms and pathology reports (where applicable) were obtained from 
the doctor for 266 of the 321 (83%) men who consented. Of these case report forms, 211/266 
(79%) were for CSEs conducted within the study period and were used in this analysis (104 
intervention, 107 control).  
Doctor-reported outcomes: Based on the case reports received from doctors, men in the 
intervention group were more likely to receive a whole-body CSE, than those in the control 
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group (75% vs 61%, p 0.05), however men in both groups were equally likely perceived by the 
doctor to have initiated the CSE  (65% vs 58%, p=0.31). Following the CSE, doctors treated, 
monitored or referred one or more lesions in 76% of participants (76% intervention, 77% 
control). Of those, 49% (104/211) of participants had non-surgical management of one or more 
lesions (50/104, 48% intervention, 54/107, 51% control). Many of those participants (86/211) 
were treated by cryotherapy. Overall, 34% (72/211) had surgical excision or biopsy of one or 
more lesions (41% intervention, 27% control; p=0.03), with median number of two lesions found 
(Table 3). Concordance between self-reported and doctor reported CSE was moderate for whole-
body CSE (Cohen’s Kappa = 0.53) and for whether any lesions were managed (Cohen’s Kappa = 
0.43).  
Pathology reports were obtained for 130 lesions that were excised or biopsied (85 intervention, 
45 control). Overall, two melanomas, 29 squamous cell carcinomas, 38 basal cell carcinomas, 17 
solar keratoses, three dysplastic naevi, nine benign nevi, and 32 other pigmented/non-pigmented 
lesions were diagnosed. The two melanomas were diagnosed in intervention participants. Thus 
the study obtained a melanoma detection rate of 2/469 (426 per 100,000). In addition, 21 SCCs 
and 28 BCCs were detected in intervention participants (n=104), and eight SCCs and 10 BCCs in 
control participants (n=107). Significantly more skin cancers were detected in the intervention 
group than the control group (60% and 40%, respectively, p=0.03) (Table 3).  
Factors positively associated with being diagnosed with a skin cancer during the trial included: 
being an intervention participant (OR=1.45; 95% CI 1.20-2.08); conducted SSE in the past six 
months (OR=1.60; 95% CI 1.04-2.48); past history of treatment for a spot or mole (OR=1.78; 
95% CI 1.19-2.67); and self-reported CSE in the past 12 months (OR=2.52; 95% CI 1.21-5.23). 
Men who rarely or never stayed in the shade and men who tanned without burning were more 
likely to be diagnosed with a skin cancer (OR=1.63; 95% CI 1.10-2.43 and OR=3.24; 95% CI 
1.42-7.38, respectively) (Table 4).  
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DISCUSSION 
While screening for melanoma by CSE for men 50+ years may be cost-effective30 it is often not 
recommended due to the absence of evidence of a mortality benefit from randomized clinical 
trials. However, data from observational studies on the value of CSE for the reduction of 
melanoma thickness and mortality is accumulating, highlighting benefit for men 50+ years. 16 31 
This study found that a video-based intervention designed to increase skin awareness, SSE, and 
presentation to a doctor with suspicious skin lesions for men 50+ years resulted in a higher 
prevalence of self-and doctor-reported whole-body CSE than the provision of written materials 
alone in men who attended for any type of CSE. Among men who had a CSE, 34% had at least 
one lesion excised or biopsied, consistent with high levels of clinical suspicion for these lesions 
and highlighting the potential value of facilitating CSEs in this group of older men in Australia.  
Compared to the control group, men receiving the video intervention were more likely to self-
report a whole body CSE. Also noted by the doctors, a larger proportion of CSEs in intervention 
participants (75%) were whole body exams –whole body exams were recommended in the video 
intervention to make certain that lesions located on difficult to see body areas were also 
assessed.6,32,33 Our analysis shows that men were more likely to self-reported CSEs if they who 
had a regular doctor, previous SSEs and/or CSEs,  previous treatment of skin lesions or moles, or 
were current concern about a skin lesion, largely similar to previous findings.34,35  The 
complementary nature of SSE and CSE has been noted previously in an investigation of skin 
cancer early detection behavior among melanoma survivors.36 
A previous trial of a video-based intervention (the Check-it-out trial),37,38 compared SSE and 
CSE outcomes among 1356 men and women (median age 52 years). The intervention included 
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educational materials provided in paper-based and video format plus individual behavioural 
counselling (one face-to-face, one telephone session). Control participants received the same 
attention, but were counselled about healthy diet. Participants randomized to the SSE group were 
significantly more likely to have skin surgery during the first six months after the intervention 
(8%), compared to 4% in the diet group. The number of malignancies found was small compared 
to our study (one melanoma, ten BCCs and three SCCs), most likely due to the younger age 
group involved and the lower skin cancer risk in the USA than Australia.8,38 Another  trial  
focusing  on improving early detection of skin cancers in men 50+years, 39  randomized men to 
receive or not to receive photographs of their skin to help detect any  changes in lesions. During 
the two year follow-up period, 34% had a skin excision, similar to the 34% observed in our 
study. The proportion of malignancies from the excised lesions (58% intervention, 42% control) 
was also similar to those observed in our study. These authors discussed whether the difference 
between intervention and control participants in overall excised lesions may have reflected 
missed lesions in the absence of photographs, or treatment of lesions by cryotherapy in the 
control participants. 39 However, in our study, the proportion of participants treated with 
cryotherapy was similar between the two groups.  Our findings indicate that in 76% of men who 
had a CSE reported by their doctor, skin lesions were discovered that required some form of 
management, of which 40% and 60% were skin cancers upon pathology report in the 
control and intervention groups, respectively. This may suggest that a targeted educational 
programme such as ours may lead to early detection of melanoma or other skin cancers. While 
the overall level of excisions may seem high, we previously reported that Australian general 
practitioners are excellent at diagnosing skin cancer, needing to excise just two skin lesions on 
average to find one skin cancer.40 Furthermore, Fransen et al reported that: “..83% of NMSC 
treatments were administered in people aged 55 years and over, and nearly two-thirds of NMSC 
treatments were administered in people aged 65 years and over.”41     
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Strengths of this study include its focus on men aged 50+ years, a group most at risk of dying 
from melanoma. Limitations include that those men who agreed to participate in the trial were 
already relatively skin aware at baseline (39% self-reported whole-body CSE 12 months before 
enrolment, with no difference between intervention and control groups). Our results could 
therefore underestimate the true effect of our intervention program, if less health-aware men are 
assumed to be more likely to carry unidentified skin cancers. A relatively low proportion of men 
gave consent for us to contact their doctors (321/540; 59%), mostly out of concern to create work 
for their doctor, although the response rate from doctors was good (266/321; 83%). This meant 
that CSE outcomes were available for 266/540 (49%) participants self-reporting a CSE. It is 
therefore likely that additional malignancies were diagnosed but not captured during the study. 
Men with fair phenotypes and previous skin excisions were more likely to consent to the doctor 
being contacted. Compared to men who consented to physician follow-up, men who did not 
consent self-reported fewer lesions being found during CSEs. Our results may thus overestimate 
somewhat the number of skin cancers that could be diagnosed if men who did not give consent 
were at lower risk of skin cancer. As previously highlighted28, Skin Awareness Study 
participants may have been more health conscious than men from general population, and 81% 
reported at baseline that they had ever had any type of skin examination by a doctor in the past. 
Our results may therefore overestimate what could be achieved in less health conscious men. 
In summary, this trial shows that men 50+ years responded favorably to video-based education, 
increasing their skin awareness and uptake of whole-body CSE during seven months of follow 
up. CSEs in men in both groups resulted in a large number of malignancies being diagnosed and 
treated. We acknowledge that routine use of CSE as a screening tool will place a burden on the 
healthcare system, and could lead to the detection of skin cancers that are relatively indolent and 
may never cause death or significant morbidity.22,25  However, with increasing evidence from 
observational studies supporting the impact of CSE on the incidence of thick melanomas and 
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mortality from melanoma,16, 31, 42and evidence for potential cost-benefit 24, these results support 
implementing behavioral interventions that encourage skin awareness for men  50+ years. 
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 Legends: 
Figure 1: Participant flow through study and clinical skin examination outcomes 
CSE: Clinical skin examination, SCC: Squamous cell carcinoma, BCC: Basal cell carcinoma 
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Table 1: Participants’ baseline demographic and health characteristics 
 Intervention group  Control group 
 n=469  (%)  n=460   (%) 
Area of Queensland        
 Urban 234  (49.9)  221  (48.0) 
 Rural 235  (50.1)  239  (52.0) 
Age group        
 50-60 years 186  (39.7)  206  (44.8) 
 61-70 years 170  (36.2)  161  (35.0) 
 71-90 years 113  (24.1)  93  (20.2) 
Highest level of education completeda        
 Less than junior high school 45  (9.6)  39  (8.5) 
 Completed junior high school 109  (23.3)  131  (28.7) 
 Completed senior high school 91  (19.4)  76  (16.6) 
 Trade or technical certificate or diploma 107  (22.8)  120  (25.8) 
 University or college degree 117  (24.9)  93  (20.4) 
Employment status        
 Employed full-time 189  (40.3)  199  (43.3) 
 Employed part-time or casual 48  (10.2)  58  (12.6) 
 Permanently ill/unable to work/looking for work 19  (4.0)  21  (4.6) 
 Retired 213  (45.4)  182  (39.6) 
Household income (yearly, before tax)        
 Less than $20,000 64  (13.6)  56  (12.2) 
 $20,001 to $40,000 131  (27.9)  111  (24.1) 
 $40,001 to $60,000 81  (17.3)  84  (18.3) 
 $60,001 to $80,000 65  (13.90  47  (10.2) 
 >$80,001 105  (22.4)  127  (27.6) 
 Refused 23  (4.9)  35  (7.6) 
Country of birth        
 Australia 363  (77.4)  360  (78.3) 
 Other 106  (22.6)  100  (21.7) 
Has a doctor ever deliberately checked any part 
of your skin for early signs of skin cancer?         
 Yes 379  (80.8)  380  (82.6) 
 No 90  (19.2)  80  (17.4) 
In the past 12 months has a doctor deliberately 
checked the skin on your whole body?         
 Yes  182  (38.8)  180  (39.1) 
 No 287  (61.2)  280  (60.9) 
Ever had a skin cancer, mole, or other spot/s 
removed or treated        
 Yes 333  (71.0)  327  (71.1) 
 No 136  (29.0)  133  (28.9) 
a Data missing for 1 participant.        
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Table 2. Self-reported outcomes of clinical skin examinations 
  
Intervention 
(n=276) 
Control  
(n=264) 
P-value 
(from χ2 
or 
Wilcoxon 
test) 
Asked by Dr to return for follow-up exam in the 
future? n (%) n (%) 
Yes 136 (49) 94 (36) <0.01 
% of patients with ≥1 lesions found during CSE 131 (47) 118 (45) 0.52 
Number of lesions where at least 1 found:  
median (range) 2 (1-28) 2 (1-20) 0.85 
% of patients with ≥1 lesions treated during CSE 116 (42) 101 (38) 0.37 
Course of treatment within those with at least 1 
lesion treated:  
Excise 59/116 (51) 43/101 (43) 0.22 
Other treatment 57/116 (49) 58/101 (57)   
Abbreviations: Dr: doctor; CSE: clinical skin examination 
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Table 3: Details from clinical skin examinations reported by doctors 
Control (n=107) Intervention (N=104)* 
  n(%) 
OR (95% 
CI) n(%) OR (95% CI) 
P-value from 
regression 
Exam initiated by: 
Participant 59 (58%) 1 (Ref) 66 (65%) 1.34 (0.76-2.35) 0.31 
Usual or another doctor 43 (42%) - 36 (35%) - 
Type of skin exam: 
Whole body 62 (61%) 1 (Ref) 76 (75%) 1.84 (1.01-3.36) 0.05 
Part of body or specific lesion 39 (39%) - 26 (25%) - 
As a result of CSE, patient 
received 
treatment/monitoring/referral 82 (77%) 1 (Ref) 79 (76%) 1.00 (0.53-1.90) 0.99 
Number of pts who had lesions 
non-surgically managed 54 (51%) 1 (Ref) 50 (48%) 0.91 (0.53-1.57) 0.73 
Number of lesions non-surgically 
managed: median (range) 9 (1-30) 3.5 (1-100) 
Cryotherapy 47 (44%)   39 (38%) 
Cream/monitoring/other 7 (7%)   11 (11%) 
Number of pts who had surgical 
management for lesions (excision 
or biopsy) 29 (27%) 1 (Ref) 43 (41%) 1.90 (1.06-3.38) 0.03 
Number of lesions excised or 
biopsied: median (range) 1 (1-5) 1 (1-8) 
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Table 3 continued:  
  Control (n=107)             Intervention (N=104)* 
         P-value  
 
Diagnoses (total lesions n): 
Melanoma 0 2 0.03** 
Squamous cell carcinoma 8 21 
Basal cell carcinoma 10 28 
Proportion malignant of total  40% 60% 
Solar keratosis 2 15 
Dysplastic naevus 1 2 
Benign naevus 7 2 
Other pigmented lesions 8 6 
Other non-pigmented lesions 9 9 
Total 45   85     
Abbreviations: CSE: clinical skin examination; pts: patients.    *Denominators vary slightly due to 
missing data; ** p-value from Chi-Square test    
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Table 4. Multivariable model factors associated with being diagnosed with a skin malignancy during the trial 
(malignant melanoma, SCC or BCC) (N=929, 40/929 diagnosed with malignancy) 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: SCC: squamous cell carcinoma; BCC: basal cell carcinoma; CI: confidence  
interval
 
  
Odds of 
diagnosis 
with skin 
malignancy
Lower 
CI limit 
Upper 
CI limit P-value 
Treatment arm 
Intervention 1.45 1.20 2.08 0.05 
Control 1.00 - - - 
Checked own skin in past 6 months at 
baseline: 
Yes 1.60 1.04 2.48 0.03 
No/Unsure 1.00 - - - 
During last skin check, did the doctor 
treat any particular spots or skin lesions? 
Yes 1.78 1.19 2.67 <0.01 
No 1.00 - - - 
In past 12 months, has a doctor 
deliberately checked any part of pt's skin 
for early signs of skin cancer? 
Yes 2.52 1.21 5.23 0.01 
No/Don't know 1.00 - - - 
Stays in the shade: 
Rarely/Never 1.63 1.10 2.43 0.02 
Sometimes/Usually/Always 1.00 - - - 
On exposure to strong sun for 30 
minutes: 0.04 
Burn and not tan 0.89 0.43 1.81 0.74 
Burn then tan 1.16 0.65 2.06 0.62 
Tan slightly without burning 1.00 - - - 
Tan a lot without burning 3.24 1.42 7.38 <0.01 
